Kezar Life Sciences, Inc. (KZR)
7.29
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 16:00
Kezar Life Sciences Gross Profit (TTM) : -0.693M for March 31, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.693M |
| December 31, 2025 | -0.897M |
| September 30, 2025 | -0.98M |
| June 30, 2025 | -1.013M |
| March 31, 2025 | -1.031M |
| December 31, 2024 | -1.04M |
| September 30, 2024 | -1.061M |
| June 30, 2024 | 5.921M |
| March 31, 2024 | 5.933M |
| December 31, 2023 | 5.934M |
| September 30, 2023 | 6.214M |
| June 30, 2023 | -0.966M |
| March 31, 2023 | -1.148M |
| December 31, 2022 | -1.306M |
| September 30, 2022 | -1.693M |
| June 30, 2022 | -1.613M |
| March 31, 2022 | -1.555M |
| December 31, 2021 | -1.51M |
| September 30, 2021 | -1.491M |
| Date | Value |
|---|---|
| June 30, 2021 | -1.558M |
| March 31, 2021 | -1.554M |
| December 31, 2020 | -1.544M |
| September 30, 2020 | -1.516M |
| June 30, 2020 | -1.404M |
| March 31, 2020 | -1.36M |
| December 31, 2019 | -1.301M |
| September 30, 2019 | -1.165M |
| June 30, 2019 | -1.037M |
| March 31, 2019 | -0.906M |
| December 31, 2018 | -0.69M |
| September 30, 2018 | -0.531M |
| June 30, 2018 | -0.369M |
| March 31, 2018 | -0.218M |
| December 31, 2017 | -0.175M |
| September 30, 2017 | -0.13M |
| June 30, 2017 | -0.087M |
| March 31, 2017 | -0.044M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| NovelStem International Corp. | 0.00 |
| Brainstorm Cell Therapeutics, Inc. | -0.179M |
| Summit Therapeutics, Inc. | -0.174M |
| Protara Therapeutics, Inc. | -0.343M |
| Clene, Inc. | -1.295M |